ArticleScience advances2022

Estimation of the in vivo neutralization potency of eCD4Ig and conditions for AAV-mediated production for SHIV long-term remission.

Ashish Goyal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.